SARS-CoV-2 vaccine breakthrough infections are asymptomatic or mildly symptomatic and are infrequently transmitted

Francesca Rovida, Irene Cassaniti, Stefania Paolucci, Elena Percivalle, Antonella Sarasini, Antonio Piralla, Federica Giardina, Jose Camilla Sammartino, Alessandro Ferrari, Federica Bergami, Alba Muzzi, Viola Novelli, Alessandro Meloni, Anna Maria Grugnetti, Giuseppina Grugnetti, Claudia Rona, Marinella Daglio, Carlo Marena, Antonio Triarico, Daniele Lilleri, Fausto Baldanti
doi: https://doi.org/10.1101/2021.06.29.21259500

Article usage

Article usage: July 2021 to September 2024

AbstractFullPdf
Jul 202123103379696
Aug 20211376526172
Sep 2021729156137
Oct 20214096967
Nov 20212034261
Dec 20211502034
Jan 20221482234
Feb 2022761821
Mar 202274258
Apr 2022691912
May 2022772614
Jun 2022381910
Jul 2022542610
Aug 202239148
Sep 2022522215
Oct 202257196
Nov 202234236
Dec 202218157
Jan 202326147
Feb 202336196
Mar 20233381
Apr 202331514
May 20231959
Jun 20232244
Jul 20231426
Aug 202324147
Sep 20232392
Oct 202315107
Nov 2023321812
Dec 20231952
Jan 20241383
Feb 202425105
Mar 20241676
Apr 2024241210
May 2024714
Jun 202435712
Jul 2024231411
Aug 20241798
Sep 20242158
Back to top
Posted July 03, 2021.
Download PDF
Data/Code
Email
SARS-CoV-2 vaccine breakthrough infections are asymptomatic or mildly symptomatic and are infrequently transmitted
Francesca Rovida, Irene Cassaniti, Stefania Paolucci, Elena Percivalle, Antonella Sarasini, Antonio Piralla, Federica Giardina, Jose Camilla Sammartino, Alessandro Ferrari, Federica Bergami, Alba Muzzi, Viola Novelli, Alessandro Meloni, Anna Maria Grugnetti, Giuseppina Grugnetti, Claudia Rona, Marinella Daglio, Carlo Marena, Antonio Triarico, Daniele Lilleri, Fausto Baldanti
medRxiv 2021.06.29.21259500; doi: https://doi.org/10.1101/2021.06.29.21259500
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area